ARCHIVES

“Harm-Reduction” Products No Proven, IOM Report Says.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

UC Davis Study Finds Patients Need Practical Information

June 28, 2002

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

November 15, 1991

Virus Cancer Program Report On Scientific Activities

August 1, 1975

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988